765 related articles for article (PubMed ID: 1875966)
1. Paracentesis with intravenous infusion of albumin as compared with peritoneovenous shunting in cirrhosis with refractory ascites.
Ginès P; Arroyo V; Vargas V; Planas R; Casafont F; Panés J; Hoyos M; Viladomiu L; Rimola A; Morillas R
N Engl J Med; 1991 Sep; 325(12):829-35. PubMed ID: 1875966
[TBL] [Abstract][Full Text] [Related]
2. Treatment of ascites in cirrhosis. Diuretics, peritoneovenous shunt, and large-volume paracentesis.
Arroyo V; Ginès P; Planas R
Gastroenterol Clin North Am; 1992 Mar; 21(1):237-56. PubMed ID: 1568775
[TBL] [Abstract][Full Text] [Related]
3. A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites.
Rössle M; Ochs A; Gülberg V; Siegerstetter V; Holl J; Deibert P; Olschewski M; Reiser M; Gerbes AL
N Engl J Med; 2000 Jun; 342(23):1701-7. PubMed ID: 10841872
[TBL] [Abstract][Full Text] [Related]
4. Peritoneovenous shunting as compared with medical treatment in patients with alcoholic cirrhosis and massive ascites. Veterans Administration Cooperative Study on Treatment of Alcoholic Cirrhosis with Ascites.
Stanley MM; Ochi S; Lee KK; Nemchausky BA; Greenlee HB; Allen JI; Allen MJ; Baum RA; Gadacz TR; Camara DS
N Engl J Med; 1989 Dec; 321(24):1632-8. PubMed ID: 2586565
[TBL] [Abstract][Full Text] [Related]
5. Treatment of patients with cirrhosis and refractory ascites using LeVeen shunt with titanium tip: comparison with therapeutic paracentesis.
Ginès A; Planas R; Angeli P; Guarner C; Salerno F; Ginès P; Saló J; Rodriguez N; Domènech E; Soriano G
Hepatology; 1995 Jul; 22(1):124-31. PubMed ID: 7601403
[TBL] [Abstract][Full Text] [Related]
6. Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis.
Ginès P; Uriz J; Calahorra B; Garcia-Tsao G; Kamath PS; Del Arbol LR; Planas R; Bosch J; Arroyo V; Rodés J
Gastroenterology; 2002 Dec; 123(6):1839-47. PubMed ID: 12454841
[TBL] [Abstract][Full Text] [Related]
7. Randomized controlled study of TIPS versus paracentesis plus albumin in cirrhosis with severe ascites.
Salerno F; Merli M; Riggio O; Cazzaniga M; Valeriano V; Pozzi M; Nicolini A; Salvatori F
Hepatology; 2004 Sep; 40(3):629-35. PubMed ID: 15349901
[TBL] [Abstract][Full Text] [Related]
8. Long-term clinical outcome of large volume paracentesis with intravenous albumin in patients with spontaneous bacterial peritonitis: a randomized prospective study.
Choi CH; Ahn SH; Kim DY; Lee SK; Park JY; Chon CY; Moon YM; Han KH
J Gastroenterol Hepatol; 2005 Aug; 20(8):1215-22. PubMed ID: 16048569
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of ascites in patients with liver cirrhosis without neither hyponatremia nor renal insufficiency. Results of a randomized study comparing diuretics and punctures compensated by albumin].
Hagège H; Ink O; Ducreux M; Pelletier G; Buffet C; Etienne JP
Gastroenterol Clin Biol; 1992; 16(10):751-5. PubMed ID: 1478401
[TBL] [Abstract][Full Text] [Related]
10. Treatment of malignant ascites in patients with advanced cancer: peritoneovenous shunt versus paracentesis.
Seike M; Maetani I; Sakai Y
J Gastroenterol Hepatol; 2007 Dec; 22(12):2161-6. PubMed ID: 18031375
[TBL] [Abstract][Full Text] [Related]
11. [Paracentesis combined with albumin infusion in the treatment of tense ascites in cirrhotic patients].
Chesta J; Brahm J; Latorre R; Gidi J; Hurtado C; Antezana C; Novoa X; Velasco M
Rev Med Chil; 1990 Aug; 118(8):874-80. PubMed ID: 2152231
[TBL] [Abstract][Full Text] [Related]
12. [Old method reevaluated. Paracentesis is effective and safe in the treatment of ascites in patients with liver cirrhosis].
Johansson A; Eriksson LS
Lakartidningen; 1992 Jul; 89(28-29):2447-50. PubMed ID: 1507965
[No Abstract] [Full Text] [Related]
13. Clinical Trial: High-dose furosemide plus small-volume hypertonic saline solutions vs. repeated paracentesis as treatment of refractory ascites.
Licata G; Tuttolomondo A; Licata A; Parrinello G; Di Raimondo D; Di Sciacca R; Cammà C; Craxì A; Paterna S; Pinto A
Aliment Pharmacol Ther; 2009 Aug; 30(3):227-35. PubMed ID: 19438847
[TBL] [Abstract][Full Text] [Related]
14. Peritoneovenous shunting for malignant ascites.
Wickremesekera SK; Stubbs RS
N Z Med J; 1997 Feb; 110(1037):33-5. PubMed ID: 9066565
[TBL] [Abstract][Full Text] [Related]
15. Prevention of paracentesis-induced circulatory dysfunction in cirrhosis: standard vs half albumin doses. A prospective, randomized, unblinded pilot study.
Alessandria C; Elia C; Mezzabotta L; Risso A; Andrealli A; Spandre M; Morgando A; Marzano A; Rizzetto M
Dig Liver Dis; 2011 Nov; 43(11):881-6. PubMed ID: 21741331
[TBL] [Abstract][Full Text] [Related]
16. [Peritoneovenous shunting in intractable ascites of cirrhosis. Results of a prospective study on improving prognostic factors].
Hillaire S; Labianca M; Smadja C; Grange D; Franco D
Gastroenterol Clin Biol; 1988 Oct; 12(10):681-6. PubMed ID: 3220223
[TBL] [Abstract][Full Text] [Related]
17. Failure of LeVeen shunting in refractory ascites--a view from the other side.
Grischkan DM; Cooperman AM; Hermann RE; Carey WD; Ferguson DR; Cook SA
Surgery; 1981 Mar; 89(3):304-8. PubMed ID: 7466618
[TBL] [Abstract][Full Text] [Related]
18. Prospective study comparing human albumin vs. reinfusion of ultrafiltrate-ascitic fluid after total paracentesis in cirrhotic patients with tense ascites.
Zaak D; Paquet KJ; Kuhn R
Z Gastroenterol; 2001 Jan; 39(1):5-10. PubMed ID: 11215366
[TBL] [Abstract][Full Text] [Related]
19. Peritoneovenous shunting of intractable ascites in patients with cirrhosis: improving results and predictive factors of failure.
Hillaire S; Labianca M; Borgonovo G; Smadja C; Grange D; Franco D
Surgery; 1993 Apr; 113(4):373-9. PubMed ID: 8456392
[TBL] [Abstract][Full Text] [Related]
20. Saphenoperitoneal shunts for patients with intractable ascites associated with chronic liver disease.
Vadeyar HJ; Doran JD; Charnley R; Ryder SD
Br J Surg; 1999 Jul; 86(7):882-5. PubMed ID: 10417558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
